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A B S T R A C T
Background: with the DSM-5 new eating disorders (EDs) diagnostic subtypes were identified within the
Other Specified Feeding or Eating Disorders (OSFED) category, which have so far been under-researched.
Objectives of this study were to examine differential features among OSFED subtypes, exploring short-
term cognitive-behavioral therapy (CBT) response and identifying clinical predictors of therapy outcome.
Methods: the sample included 176 female patients diagnosed with OSFED [82 atypical anorexia nervosa
(atypical-AN), 57 purging disorder (PD), and 37 subthreshold bulimia nervosa (sub-BN)]. Assessment
included eating-related, psychopathological and personality measures.
Results: results showed similar clinical and personality profiles between the diagnostic subtypes, with
hardly any differences, only observable in the core symptoms of each diagnosis. The sub-BN group was
the one which showed more social impairment. Regarding treatment outcome, the three groups did not
reveal significant differences in remission rates, therapeutic adherence or dropout rates, reaching rates of
dropout from 36.8% to 50% (p = .391). However, different ED subtype predictors appear related with full
remission or dropout risk, specifically personality traits.
Conclusions: our results suggest that OSFED patients may benefit similarly from the same CBT outpatient
group approach. However, high dropout rates and low motivation seems to be an important limitation
and challenge for future approaches.
© 2018 Elsevier Masson SAS. All rights reserved.
Contents lists available at ScienceDirect
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Most studies in eating disorders (ED) have mainly focused on
anorexia nervosa (AN), bulimia nervosa (BN), and recently on
binge eating disorder (BED), neglecting other residual or
subthreshold ED such as eating disorder not otherwise specified
(EDNOS). Based on the Diagnostic and Statistical Manual of
Mental Disorders fourth edition (DSM-IV-TR) [1], EDNOS category
was defined as a broad hodgepodge that includes many
heterogeneous and not well-defined ED cases (i.e. those who
do not fulfill the diagnostic criteria for AN or BN). The update of* Corresponding authors at: Department of Psychiatry, University Hospital of
Bellvitge-IDIBELL and CIBEROBN, c/ Feixa Llarga s/n, 08907, Barcelona, Spain.
E-mail addresses: zaguera@bellvitgehospital.cat (Z. Agüera),
ffernandez@bellvitgehospital.cat (F. Fernández-Aranda).
1 Shared first authorship.
http://dx.doi.org/10.1016/j.eurpsy.2018.08.001
0924-9338/© 2018 Elsevier Masson SAS. All rights reserved.the DSM-5 [2] reconfigured and renamed EDNOS as other
specified feeding or eating disorder (OSFED). OSFED is a formal
diagnostic category including heterogeneous nosological entities,
such as: atypical anorexia nervosa (atypical-AN), purging disor-
der (PD), subthreshold bulimia nervosa (Sub-BN), subthreshold
binge eating disorder (Sub-BED), and night eating syndrome
(NES). These changes into the diagnostic framework of ED aimed
to reduce the overrepresentation of cases in this residual category
of EDNOS [3–6], as well as it attempts to enhance the study of
more homogeneous phenotypes [7].
However, because this nosology is relatively recent, most of the
research in this field refers to EDNOS, while OSFED subtypes have
barely been studied in the literature so far. Due to the vast majority
of diagnoses in clinical practice fall within the atypical/subthresh-
old ED umbrella [8], this diagnosis has been reported as the most
prevalent ED [9–13], but often not less severe and enduring than
full syndromes [8,14,15]. Epidemiological studies show that the
prevalence of OSFED is about 1.5%, less than half of the prevalence
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some few studies revealed prevalence rates range between 1.1–
5.3% for lifetime PD, 2.8–3.6% for atypical-AN, 4.4% for Sub-BN, and
1.5–5.7 % for NES [7,17,18]. Nevertheless, these prevalence data are
regarding specific community samples (mainly adolescent pop-
ulations), and they are not generalizable to other populations such
as clinical or adult samples.
Despite the relevance, chronicity and considerable clinical
severity of OSFED [16] there is a lack of research analyzing therapy
outcomes. The few studies comparing response to treatment
between atypical/subthreshold ED and full syndromes found
similar patterns of remission and relapse [19–21], but also high
dropout rates among the formers [22]. Heterogeneous results
among diagnostic subtypes have been described in the literature,
with PD patients showing the best prognosis [23], whereas
atypical-AN and sub-BN patients not showing differences with the
full-threshold EDs [24]. Moreover, although data on diagnostic
crossover in EDNOS/OSFED are sparse, available findings suggest
that approximately 40% of these patients develop AN or BN later in
life [25].
Taking into account all the aforementioned gaps in the
literature, mainly contradictory findings and studies where
atypical/subthreshold ED represented a negligible portion of the
sample, it is not possible to generalize results or define a clear
hypothesis about treatment outcome in these clinical populations.
Therefore, in the present study we were focusing in the most
prevalent OSFED subtypes (namely, atypical-AN, PD, and sub-BN),
with the following goals: (a) to examine clinical, motivational,
psychopathological, and personality differences among the
groups; (b) to explore short-term treatment outcome, therapeutic
adherence, and dropout rates; and (c) to identify clinical predictors
of therapy outcomes. To our knowledge, this is the first study
assessing treatment outcome and dropout rates between well-
differentiated OSFED subtypes following outpatient cognitive-
behavioral therapy (CBT), which may contribute to advancements
in the debate about whether these diagnostic subtypes would
benefit equally from a joint CBT treatment. Also, the findings
derived from the study might improve our ability to identify and




The present study was approved by the Ethics Committee of the
University Hospital of Bellvitge and all the participants provided
signed informed consent.
2.2. Participants
The initial sample consisted of 201 patients with OSFED,
consecutively admitted for treatment at the Eating Disorders Unit
of the Bellvitge University Hospital. Of those, were excluded: 8 men
(3.9%), 9 females with subthreshold BED (4.5%), and 8 females with
unspecified feeding and eating disorders (UFED) (3.9%) because the
number was too small for meaningful comparisons. Therefore, the
final sample comprised 176 female patients diagnosed with OSFED
(82 atypical-AN, 57 PD, and 37 sub-BN). All patients admitted
before May of 2013 were originally diagnosed using the DSM-IV-TR
[1]. Diagnoses were made by means of a face-to-face semi-
structured clinical interview, based on the SCID-I [26], and
conducted by experienced clinical psychologists and psychiatrists.
Diagnoses were reanalyzed post hoc using DSM-5 criteria [2].
Exclusion criteria were: (a) patients aged <18 years old; (b)
patients presented with severe comorbid psychopathologicalsymptoms (e.g. risk of suicidal attempt or psychotic/bipolar
disorders) requiring individual therapy and/or inpatient therapy.
2.3. Assessment
- Eating disorders inventory-2 questionnaire (EDI-2) [27] (Spanish
validation [28]) to assess behavioral and psychological dimen-
sions of the ED. The internal consistency for the current sample
was excellent (α = .94).
- Symptom Checklist-90-Revised (SCL-90-R) [29] (Spanish valida-
tion [30]). This questionnaire was designed to assess psycho-
pathological distress. The internal consistency of our sample
was excellent (α = .97).
- Temperament and Character Inventory-Revised (TCI-R) [31]
(Spanish validation [32]). This questionnaire consists of 240
items that measure temperament and character dimensions.
Cronbach’s alpha for the current sample was good for “novelty
seeking” (α = .78) to excellent (α = .90) for “harm avoidance”.
- Motivational stage. The motivational stage of change was
assessed through five visual analogue scales named: subjective
desire for treatment, need of treatment; impairment, Worry
[Self], and Worry [Family]. The scales ranged from 0 to 8, with 8
being the maximum score indicating worry and motivation for
change. The scale has been previously described and applied in
ED patients [33].
Additional information such as sociodemographic variables,
impulsive behaviours, and other relevant clinical variables were
assessed by means of a face-to-face semi-structured clinical
interview [34].
2.4. Treatment
The National Institute for Health and Care Excellence (NICE
guideline Published: 23 May 2017 nice.org.uk/guidance/ng69)
recommends implementing the first-line treatment for the most
closely resembling ED, being the cognitive behavioural therapy-
Enhanced (CBT-E) the recommended treatment for adult patients
with EDs.
Treatment for OSFED consisted of 16 weekly outpatient
group therapy conducted by experienced psychologist. All
patients were treated in the same set of therapy group. Despite
the distinct OSFED subtypes present heterogeneous clinical and
symptomatological features, the treatment addresses the core
characteristics that are common in the full spectrum of ED,
such as training in problem solving strategies, cognitive
restructuring, emotion regulation, improving self-esteem and
body image, and relapse prevention strategies. In addition,
therapy aimed to address eating-related symptomatology,
introducing eating monitoring, regular nutritional patterns
and increasing knowledge about negative consequences of the
disorder. The treatment protocol was manualized and pub-
lished in Spanish [34].
Patients were re-evaluated at discharge and categorized
into the following three categories: full remission, partial
remission, and non-remission. According to DSM-5 criteria
[2], the working definition of full remission was a total absence
of symptoms meeting diagnostic criteria for at least 4 consecu-
tive weeks, partial remission was defined as substantial
symptomatic improvement but with residual symptoms, and
the patients who presented poor outcomes were defined as non-
remission. These categories were previously used to assess
treatment outcome in threshold ED in other published studies
[35–37]. Voluntary treatment discontinuation was categorized as
dropout (i.e. not attending treatment for at least three
consecutive sessions).
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Analyses were carried out with Stata15 for Windows. First, the
comparison between the diagnostic subtypes was based on chi-
square tests (2) for categorical variables and in analysis of variance
(ANOVA) for quantitative measures. Effect size was estimated
through the Cohen’s-d coefficient, considering moderate effect size
for |d|>0.50 and high effect size for |d|>0.80 [38]. To avoid increase
in Type-I error due to multiple statistical comparison, Finner’s
procedure was employed [39], a method included into the
Familywise error rate stepwise procedures, and offers more
powerful test than the classical Bonferroni correction.
Kaplan-Meier functions estimated the cumulative survival for
the time to dropout. This method, also known as the product-limit-
estimator, is a non-parametric procedure to estimate the survival
function from “lifetime data”, and in the area of the Health Sciences
it is often used to measure the proportion of patient “living”
(surviving) for an amount of time after one event. In this study, the
Kaplan-Meier estimator measured the length of time that patients
remain participant (without dropout). Overall comparison of
cumulate survival functions between the three diagnostic groups
was done with the Log-Rank, Breslow and Tarone-Ware tests.
Finally, logistic regressions generated predictive models of the
main therapy outcomes of the study: the risk of dropout and the
risk of good therapy outcome (partial or full remission). Stepwise
procedure was used to automatically select the variables with most
predictive capacity, and the models were generated separately/
stratified for each diagnostic condition. The goodness-of-fit for the
final models were valued with the Hosmer-Lemeshow test
(adequate fitting was considered for p > 0.05), the overall predic-
tive capacity with the Nagelkerke’s pseudo-R2 coefficient and the
discriminative capacity to differentiate between the groups with
the area under the ROC curve.
3. Results
3.1. Characteristics of the sample
Table 1 contains the descriptive for the sociodemographics in
the sample of the study, and the comparison between the
diagnostic subtypes. Many participants were single (77.3%), with
primary (33.5%) or secondary (46.0%) studies, and employed orTable 1







n % n % n % χ2 df p
Origin
Spanish 77 93.9 53 93.0 36 97.3 0.83 2 .661
Immigrant 5 6.1 4 7.0 1 2.7
Civil status
Single 68 82.9 40 70.2 28 75.7 5.94 4 .204
Married-couple 7 8.5 13 22.8 5 13.5
Divorced 7 8.5 4 7.0 4 10.8
Education level
Primary 33 40.2 14 24.6 12 32.4 5.13 4 .274
Secondary 36 43.9 30 52.6 15 40.5
University 13 15.9 13 22.8 10 27.0
Employment
Unemployed 23 28.0 14 24.6 14 37.8 1.99 2 .370
Employed 59 72.0 43 75.4 23 62.2
Note. AN: anorexia nervosa. PD: purging disorder. Sub-BN: subthreshold bulimia
nervosa.studying (71.0%). No statistical differences between groups were
found.
3.2. Comparison of the clinical profile at baseline between the
diagnostic groups
Table 2 contains the comparison between the groups for the
categorical clinical variables of the study. For the whole sample, the
prevalence of childhood obesity was 13.1%. The 12.5% of the
participants reported lifetime overweight. Non-suicidal self-harm
behaviors were present in 30.7% of the sample, suicidal ideation in
40.9%, and suicidal attempts in 11.9%. In relation to the use/abuse of
substances: 36.4% indicated tobacco use, 6.8% alcohol use-abuse,
and 16.5% recognize to consume other illegal drugs. No differences
between the groups were obtained for this set of variables.
Table 3 contains the comparison between the groups for the
quantitative clinical variables. Age of onset and duration of the
disorder differed between the groups, being the PD subtype who
has the latest age of onset, and the sub-BN the group with the
longest duration of the disorder. Body mass index (BMI) measures
also differed among the groups, being the atypical-AN phenotype
the group with the lowest mean values, followed by the PD
phenotype and lastly the sub-BN group. For the motivational
scales, differences only emerged for the social impairment of daily
tasks variable, which mean score was the highest for the sub-BN
subtype. As expected, the frequency of vomits and laxatives
achieved the highest mean in the PD group, followed by the sub-BN
and the atypical-AN. Regarding EDI-2 scales, as a whole the highest
means were obtained for the sub-BN, followed by the PD group and
the atypical-AN. No statistical differences were found comparing
the mean scores for the SCL-90R scales, and the only difference for
the TCI-R scales was obtained for the persistence dimension (the
highest mean was shown in the PD group, while no statistical
difference emerged comparing atypical-AN and sub-BN).
3.3. Comparison of the therapy outcome between the diagnostic
groups
The first part of Table 4 contains the comparison of the therapy
outcome group (dropout, non-remission, partial-remission and
full remission) between the three diagnostic conditions, and the
second part of Table 4 the comparison for the number of attended
sessions. Dropouts ranged between 36.8% and 50% among the
groups. No statistical difference emerged comparing the three
diagnostic subtypes. From those OSFED patients who completed
treatment (n = 99; 56.6%), the 72.7% (n = 72) of the patients
obtained good outcome (46.5% partial remission and 26.3% full
remission) whereas the 27.3% of the completers presented non-
remission.Table 2







n % n % n % χ2df=2 p
Childhood obesity 8 9.8 9 15.8 6 16.2 1.49 .476
Childhood overweight 11 13.4 6 10.5 5 13.5 0.30 .861
Self-harm behavior 27 32.9 17 29.8 10 27.0 0.45 .800
Suicidal attempts 6 7.3 9 15.8 6 16.2 3.12 .211
Suicidal ideation 33 40.2 19 33.3 20 54.1 4.01 .134
Tobacco use 29 35.4 26 45.6 9 24.3 4.46 .107
Alcohol use-abuse 7 8.5 1 1.8 4 10.8 3.61 .164
Drugs use-abuse 12 14.6 7 12.3 10 27.0 3.92 .141
Note. AN: anorexia nervosa. PD: purging disorder. Sub-BN: subthreshold bulimia
nervosa.
p-value includes Bonferroni-Finner’s correction for multiple comparison.
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Mean SD Mean SD Mean SD Fdf=173 p MD p |d| MD p |d| MD p |d|
Age (yrs-old) 25.23 7.64 27.39 8.98 27.35 8.15 1.49 .227 2.15 .129 0.26 2.12 .193 0.27 0.03 .984 0.00
Onset (yrs-old) 18.00 5.02 21.77 7.75 17.86 5.12 7.64 .001* 3.77 <.001* 0.58† 0.14 .910 0.03 3.91 .003* 0.59†
Duration (yrs) 6.79 6.18 5.38 5.52 8.81 7.77 3.29 .040* 1.42 .197 0.24 2.02 .111 0.29 3.44 .011* 0.51†
BMI: maximum 23.61 3.44 26.21 4.92 27.83 5.26 13.52 <.001* 2.60 .001* 0.61† 4.22 <.001* 0.95† 1.61 .083 0.32
BMI: minimum 17.98 1.71 19.41 1.99 19.93 2.06 17.42 <.001* 1.43 <.001* 0.77† 1.95 <.001* 1.03† 0.52 .192 0.26
BMI: baseline 19.74 1.43 21.80 3.61 23.75 3.76 26.80 <.001* 2.05 <.001* 0.75† 4.01 <.001* 1.41† 1.96 .001* 0.53†
ED: intensity 4.77 1.66 5.05 1.89 5.08 2.24 0.55 .578 0.28 .379 0.16 0.31 .399 0.16 0.03 .943 0.01
ED: therapy need 5.23 2.33 5.72 1.91 5.89 2.00 1.56 .213 0.49 .186 0.23 0.66 .120 0.30 0.17 .702 0.09
ED: social distress 4.66 2.30 4.88 2.01 5.70 1.81 3.16 .045* 0.22 .549 0.10 1.04 .014* 0.50† 0.83 .066 0.43
ED: troubles 5.40 2.14 6.00 1.94 6.14 2.06 2.23 .110 0.60 .094 0.29 0.73 .074 0.35 0.14 .756 0.07
ED: family trouble 6.71 1.82 6.84 1.63 5.97 2.34 2.65 .073 0.13 .679 0.08 0.73 .051 0.35 0.87 .055 0.43
# previous treat. 0.68 0.95 0.33 0.55 0.49 0.77 3.25 .041* 0.35 .013* 0.45 0.20 .219 0.23 0.15 .368 0.23
Binges 0.52 1.22 0.76 1.87 0.19 0.26 1.97 .142 0.24 .297 0.16 0.33 .230 0.37 0.57 .049* 0.43
Vomits 0.91 2.73 6.23 6.20 2.37 4.48 24.00 <.001* 5.31 <.001* 1.11† 1.45 .104 0.39 3.86 <.001* 0.71†
Laxatives 0.85 3.66 4.39 12.20 1.19 3.63 3.98 .020* 3.53 .007* 0.39 0.34 .823 0.09 3.20 .047* 0.36
EDI-2 scales
Drive for thinness 14.60 5.61 16.56 4.74 16.38 4.66 2.97 .049* 1.96 .028* 0.38 1.78 .083 0.35 0.18 .867 0.04
Body dissatisf. 15.00 7.96 18.32 7.78 18.57 7.55 4.19 .017* 3.32 .015* 0.42 3.57 .022* 0.46 0.25 .879 0.03
Interocep. awaren. 9.78 6.24 12.54 6.16 12.73 7.91 4.05 .019* 2.76 .016* 0.45 2.95 .025* 0.41 0.19 .894 0.03
Bulimia 2.85 2.71 5.98 5.14 8.16 5.20 22.79 <.001* 3.13 <.001* 0.76† 5.31 <.001* 1.28† 2.18 .015* 0.42
Interpers. distrust 4.67 4.90 6.67 4.73 5.16 4.96 2.91 .048* 2.00 .018* 0.41 0.49 .610 0.10 1.50 .144 0.31
Ineffectiveness 10.34 6.96 9.98 6.04 11.49 8.39 0.54 .583 0.36 .767 0.06 1.15 .411 0.15 1.50 .311 0.21
Maturity fears 8.39 6.18 7.44 5.55 7.22 5.14 0.73 .485 0.95 .341 0.16 1.17 .306 0.21 0.22 .855 0.04
Perfectionism 5.06 3.70 6.25 4.09 5.59 4.27 1.51 .223 1.18 .084 0.30 0.53 .496 0.13 0.65 .436 0.16
Impulse regulation 6.24 5.73 6.02 4.84 7.49 6.89 0.82 .442 0.23 .819 0.04 1.24 .275 0.20 1.47 .226 0.25
Ascetic 6.48 3.83 7.23 3.94 7.97 4.00 1.98 .141 0.75 .265 0.19 1.50 .054 0.38 0.74 .367 0.19
Social insecurity 6.88 4.43 7.42 4.26 7.59 5.66 0.39 .676 0.54 .500 0.12 0.72 .439 0.14 0.17 .860 0.03
Total score 90.37 38.75 104.40 35.98 108.35 47.10 3.47 .033* 14.04 .042* 0.38 17.99 .024* 0.42 3.95 .639 0.09
SCL-90R scales
Somatization 1.63 0.85 1.94 0.85 1.70 1.05 2.12 .123 0.31 .055 0.37 0.07 .674 0.08 0.24 .207 0.25
Obsess./compul. 1.76 0.78 1.80 0.81 1.85 0.87 0.19 .825 0.04 .768 0.05 0.10 .539 0.12 0.06 .737 0.07
Interper. sensit. 1.97 0.87 2.03 0.72 2.13 0.97 0.46 .633 0.06 .675 0.08 0.16 .341 0.17 0.10 .581 0.12
Depressive 2.11 0.85 2.22 0.72 2.22 0.99 0.44 .643 0.12 .409 0.15 0.12 .477 0.13 0.00 .995 0.00
Anxiety 1.65 0.85 1.77 0.88 1.62 0.96 0.40 .674 0.11 .452 0.13 0.03 .864 0.03 0.15 .438 0.16
Hostility 1.37 0.97 1.42 0.94 1.37 1.06 0.05 .951 0.05 .767 0.05 0.00 .995 0.00 0.05 .813 0.05
Phobic anxiety 0.92 0.77 1.00 0.88 1.25 1.00 1.92 .149 0.08 .587 0.10 0.33 .052 0.37 0.25 .167 0.27
Paranoid Ideation 1.37 0.78 1.51 0.71 1.48 0.87 0.53 .587 0.13 .330 0.18 0.10 .507 0.12 0.03 .862 0.04
Psychotic 1.32 0.72 1.29 0.74 1.26 0.85 0.09 .912 0.03 .801 0.04 0.06 .679 0.08 0.03 .854 0.04
GSI score 1.65 0.69 1.76 0.64 1.74 0.82 0.53 .592 0.12 .339 0.17 0.10 .497 0.13 0.02 .885 0.03
PST score 64.33 16.87 66.91 14.98 62.62 18.46 0.81 .447 2.58 .369 0.16 1.71 .605 0.10 4.29 .223 0.26
PSDI score 2.23 0.53 2.33 0.50 2.40 0.59 1.47 .233 0.10 .295 0.19 0.17 .103 0.31 0.08 .497 0.14
TCI-R scales
Novelty seeking 99.15 14.29 103.0 17.31 102.1 15.44 1.17 .313 3.91 .147 0.25 2.96 .338 0.20 0.94 .774 0.06
Harm avoidance 119.1 20.83 116.3 19.57 117.2 21.82 0.33 .720 2.81 .432 0.14 1.88 .646 0.09 0.93 .832 0.04
Reward depend. 104.5 14.72 100.3 18.21 104.9 16.12 1.39 .252 4.21 .134 0.25 0.41 .899 0.03 4.62 .179 0.27
Persistence 109.3 19.01 116.2 22.01 108.5 18.92 2.49 .050* 6.90 .047* 0.34 0.83 .835 0.04 7.73 .048* 0.38
Self-directedn. 121.4 21.28 119.2 20.21 120.1 22.42 0.19 .829 2.21 .545 0.11 1.26 .765 0.06 0.96 .830 0.04
Cooperativ. 133.7 17.20 136.3 16.70 135.9 20.45 0.41 .664 2.57 .404 0.15 2.19 .535 0.12 0.38 .920 0.02
Self-Transcen. 62.28 14.95 60.67 11.95 65.05 18.48 0.97 .380 1.61 .531 0.12 2.77 .349 0.16 4.39 .165 0.28
Note. AN: anorexia nervosa. PD: purging disorder. Sub-BN: subthreshold bulimia nervosa. SD: standard deviation. p-value includes Bonferroni-Finner’s correction.
* Bold: significant comparison (.05 level).
† Bold: effect size into the moderate (|d|>0.50) to good range (|d|>0.80).
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Meier estimation) for the time to the dropout of the study. As a
whole, the highest risk of dropout and the highest rate was
observed in the atypical-AN, nearly followed the other two
diagnostic subtypes. Overall comparisons did not achieve statisti-
cal differences (p > 0.05 for the Log-Rank, Breslow and Tarone-
Ware tests). The dropouts were constantly distributed along the
whole therapy sessions.
3.4. Predictive models of the therapy outcomes
Table 5 contains the final models with the variables with
the best predictive capacity on the therapy outcomes dropoutand partial-full remission. The list of potential predictors
included EDI-2 total score, SCL-90R total score, personality
profile measured through the TCI-R scales, chronological age,
age at onset of the ED, duration of the disorder, BMI,
motivational scales and frequency of binges-laxatives-vomits.
The risk of dropout was increased differentially among the
OSFED groups: (a) for atypical-AN by high frequency of
binges-per-week, high scores in the novelty seeking trait, low
levels in the self transcendence trait and low self-concern
about the ED (Worry [Self]); (b) for PD by low scores in the
personality traits of harm avoidance, reward dependence and
self directedness; and (c) for sub-BN by high frequency of
laxatives-per-week.
Table 4
Comparison of therapy outcome.
Atypical-AN PD Sub-BN
(n = 82) (n = 57) (n = 37)
n % n % n % χ2 df p
Dropout 41 50.0 21 36.8 15 40.5 6.30 6 .391
Non-remission 11 13.4 12 21.1 4 10.8
Partial-remission 22 26.8 14 24.6 10 27.0
Full remission 8 9.8 10 17.5 8 21.6
Mean SD Mean SD Mean SD Wald df p
aAttended sessions 9.11 5.2 9.95 4.6 9.76 5.5 0.26 2 .877
Note. AN: anorexia nervosa. PD: purging disorder. Sub-BN: subthreshold bulimia
nervosa. SD: standard deviation.
a Results obtained in negative binomial model.
Fig. 1. Cumulative survival function for the time to dropout the therapy.
Table 5
Predictive models of the therapy outcomes dropout and remission: stepwise logistic re
Outcome: dropout 
Atypical-AN B SE p OR At
Frequency of binges 0.390 0.233 .046 1.48 TC
TCI-R: novelty seeking 0.064 0.021 .001 1.07 Ne
TCI-R: self-transcendence 0.037 0.019 .039 0.96 Co
Worry (Self) 0.205 0.123 .048 0.81 Fi
Constant 3.186 2.112
Fitting: HL test, R2, AUC .065 .273 .795
Purging disorder B SE p OR Pu
TCI-R: harm avoidance 0.079 0.024 .001 .92 TC
TCI-R: reward dependence 0.049 0.022 .025 .95 TC
TCI-R: self-directedness 0.042 0.020 .035 .96 TC
Constant 18.279 5.428 W
Fitting: HL test, R2, AUC .902 .321 .847 Co
Fi
Sub-BN B SE p OR Su
Frequency of laxatives 0.897 0.538 .002 2.45 Fr
Constant 0.861 0.397 TC
Fitting: HL test, R2, AUC .882 .222 .683 De
Co
Fi
Note. AN: anorexia nervosa; Sub-BN: sub threshold bulimia nervosa.
Note. List of predictors considered for the predictive models: EDI-2 total, SCL-90R GSI, p
duration of the disorder, BMI (maximum, minimum and current), motivational scales a
HL: Hosmer-Lemeshow test (p-value). AUC: area under ROC curve.
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increased differentially among the OSFED groups: (a) for atypical-
AN by low scores in the novelty seeking personality trait and high
perceived need of treatment; (b) for PD by high scores in the
personality scales of harm avoidance, persistence and self
directedness, and low Worry [Self]); and (c) for sub-BN by low
frequency of laxatives-per-week, high levels in the self transcen-
dence personality trait and low intensity perceived of the ED.
4. Discussion
The present study attempted to address an important gap in the
literature, analyzing and comparing clinical and therapeutic
features between different OSFED subtypes and, therefore,
obtaining a better understanding of these ED. Moreover, since a
good diagnostic categorization requires information regarding
treatment outcome, the present study also aimed to analyze
response to treatment, therapeutic adherence and predictors of
therapy outcome among the different OSFED phenotypes.
The first main objective was to examine clinical differences
between the most prevalent OSFED phenotypes. In agreement with
other studies [24], our results showed that, overall, the three
OSFED groups, besides of their symptomatological heterogeneity,
share common eating and general psychopathological symptoms
as well as personality traits [17]. With regard to eating-related
symptoms, the only meaningful difference was revealed in purging
symptomatology, being the PD cases the ones who presented the
highest frequency of vomiting and laxatives use. This result is not
surprising since a recurrent purging behavior is the core symptom
of this diagnostic subtype [2]. Our results are also in line with
previous studies which found that purging patients engaged in
more frequent laxatives use as compensatory behavior [24,40]. On
the other hand, our results showed that the atypical-AN group
showed the lowest scores in the EDI-2 bulimia subscale. These
results were the expected ones because, unlike the other twogression.
Outcome: partial or full remission
ypical-AN B SE p OR
I-R: novelty seeking 0.044 0.019 .021 0.96
ed of treatment 0.279 0.120 .020 1.32
nstant 2.253 1.983
tting: HL test, R2, AUC .519 .208 .733
rging disorder B SE Wald OR
I-R: harm avoidance 0.080 0.026 .002 1.08
I-R: persistence 0.033 0.017 .048 1.03
I-R: self-directedness 0.048 0.020 .017 1.05
orry (Self) 0.493 0.199 .013 0.61
nstant 16.30 5.154
tting: HL test, R2, AUC .313 .301 .831
b-BN B SE Wald OR
equency laxatives 0.827 0.547 .131 0.44
I-R: self-transcendence 0.058 0.028 .038 1.06
sire for treatment 0.369 0.208 .076 0.69
nstant 1.472 1.599
tting: HL test, R2, AUC .372 .293 .823
ersonality profile measured with the TCI-R scales, chronological age, age of onset,
nd frequencies of binges-laxatives-vomits.
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behaviours for their diagnosis.
Patients with PD also presented a later age of onset, while sub-
BN had significantly longer duration of the illness. These findings
are similar to those reported in previous studies [23] indicating
that PD is found to be rare before age 18 [41], and most typically
first onsets are at approximately 20 years of age [7]. In this
regards, previous studies have suggested that unhealthy weight
control behaviors, such as purging behaviors, may appear as a
mechanism to compensate the decline in physical activity and,
therefore, energy balance dysregulation, which occurs in the late
adolescence [17]. On the other hand and not surprisingly,
atypical-AN group presented lower BMI lifetime than the others.
Although the diagnostic criteria for atypical-AN does not require
meting the low weight of AN [2], these patients present severe
weight control strategies (restriction) which may justify these
results.
Not surprisingly and consistent with prior literature [33], our
results indicated that patients with OSFED report low motivation
to change. When comparing the standardized scores of motivation
for treatment between our OSFED patients and the full syndrome
scores (based on the study of Casanovas et al. [33]), the former
showed even lower scores (see supplemental files). In addition, no
differences between the three groups were found, with the sole
exception of a greater social impairment perceived by the sub-BN
group. This result is consistent with previous research stating that
binge eaters usually refer increased impairment in the social life
and in the leisure activities because the binge-eating behaviors are
associated with greater psychiatric comorbidity, distress and
functional impairment [42–44].
Regarding treatment outcome, the rates of good remission
in our sample ranged from 36.6% to 48.6% among the three
phenotypes. These findings support other research which found
an average percentage of remission of 40–45% [24]. However, they
are not in accordance with others presenting recovery rates of
91% for sub-BN and 95% for PD [41]. These discrepancies are
probably due to the fact that the study of Stice et al. [41] analyzed
patients diagnosed with EDNOS according to DSM-IV and,
therefore, more heterogeneous samples. Also, these authors
analyzed adolescents from community samples and not adult
ED patients who were seeking treatment, which may contribute
to these contradictory results, since the latter probably present
more chronic and severe eating pathology. In addition, no
differences in remission rates were found between the three.
In the same vein, a prior study found similar treatment outcome
between the OSFED groups, but also between OSFED groups and
ED full syndromes [24].
As regards dropout rates and therapeutic adherence, patients
from the three OSFED diagnoses attended roughly the same
number of therapy sessions and showed increased rates of dropout
(36.8%–50%), which suggests that these patients are less motivated
for treatment than full diagnoses of AN or BN, maybe because
these patients generally exhibit less severe physical symptoms
[45]. However, subthreshold diagnoses are not trivial and they
should not be underestimated since they are disorders with severe
comorbidity and similar chronicity to full syndromes [46].
Curiously, the survival analysis showed a constant and progressive
evolution of the risk of dropout in all three groups. The lack of
therapeutic adherence suggests that further research is needed to
address the lack of motivation, beliefs about the disorder,
perception about the control of the disease itself or awareness
of disabilities derived from the disorder [47]. In this sense, Lask
and Framptom [48] describe anosognosia associated with ED
where the patient fluctuates from having insight into their
disorder to moving to denial. This raises new premises about
therapeutic targets. Future research should assess and comparekey maintenance factors, such as denial of illness, lack of
awareness, anosognosia or impaired insight [49], as well as their
association with therapy outcome. This will benefit clinicians to
obtain a better conceptual understanding of the processes
involved in the treatment of these patients. In this vein, it should
be stated that motivational enhancement therapy interventions
may be particularly important for those individuals diagnosed
with OSFED [50].
Finally, in terms of primary predictors of treatment outcome,
our results were similar to those obtained in the literature on full
ED syndromes, namely higher dropout and poorer therapy
outcome associated to lower motivation and more dysfunctional
personality traits. However, we found specific characteristics
associated with the prognosis of each diagnostic subtype. First, for
Atypical-AN, a higher novelty seeking and lower self-transcen-
dence were associated with increased risk of dropout and less
remission rates (although the three OSFED groups showed
normative scores in novelty seeking [32]). Also for atypical-AN,
a poor motivational stage with low concern for the disorder and
lack of perceived need of treatment was related to worse prognosis.
Second, for PD, lower scores on some personality traits such as
harm avoidance, reward dependence, self-directedness and
persistence were related to higher risk of dropout and poor
outcome. Although the association between high harm avoidance
and better prognosis in PD seems to be a striking and unexpected
finding, it may suggest that patients with anticipatory worry, great
sensitivity for criticism and fear of uncertainty [51] are more
concerned about their disorder and, therefore, more motivated for
treatment [52]. Lastly, for the sub-BN group, high score on self-
transcendence was the main predictor of therapy outcome.
Unfortunately, we are not able to contrast our findings with
previous studies, since no study has assessed the specific
predictors of treatment outcome for the different diagnostic types
of OSFED so far.
4.1. Limitations and strengths
The present study should be evaluated within the context of its
several limitations. First, this study is limited by the lack of other
diagnostic types of the wide spectrum of OSFED. It would have
been useful to compare all OSFED but, unfortunately, we did not
have enough sample size to make meaningful comparisons.
Second, we included only adult female patients with ED. Hence,
we cannot confirm whether our results are generalizable to
adolescent or males with the same diagnosis. Third, not all the
patients were naïve. That is, some patients were in a stage of the
disorder with residual symptoms after a partial remission of the
full-threshold disorders of AN or BN (diagnostic crossover). Hence,
further studies assessing separately naïve and diagnostic crossover
patients are needed for guaranteeing the homogeneity of the
sample. Finally, our findings are mainly about symptomatological
remission after the therapy, but not recovery (the term ‘recovery’
requires a long period of abstinence from ED symptomatology).
Hence, further longitudinal studies collecting follow-up data are
needed to replicate this study in order to assess whether there are
differential rates of relapse or recovery.
Notwithstanding these limitations, the current study has also
several strengths that should be noted. For the first time we have
addressed treatment response across a large sample of adult
females with different diagnostic types that fit into OSFED
category. As far as we know, this is the first study assessing
specific predictors of outcomes in these patients. A better
description of the clinical features and treatment outcome of
the distinct ED phenotypes, including subthreshold types, would
most likely enhance its detection and diagnosis in clinical practice,
mitigating diagnostic confusion [7].
N. Riesco et al. / European Psychiatry 54 (2018) 109–116 1154.2. Conclusions
In sum, our findings revealed that the three OSFED subtypes
were more similar than distinct in terms of clinical, psychopatho-
logical and personality features. Regarding treatment outcome, our
findings suggest that OSFED patients, who complete the therapy,
may benefit from the same treatment. However, the high dropout
rates open the debate and highlight the need to add other
therapeutic tools for improving the therapeutic adherence of these
patients, for example, family, motivational or insight-based
treatments.
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